Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biogen
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
clinical trials
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
astrazeneca
cancer
cancer immunotherapy
fda
gene therapy
glaxosmithkline
johnson & johnson
What
bio
roundup
biotech
drug
news
alzheimer’s
annual
approval
assessed
attention
august
biogen’s
biopharmaceutical
busy
communities
companies
conference
convo
days
decisions
devices
drugs
earlier
esmo
europe
failures
fda
germany
hosted
investment
legacy
littered
munich
nash
new
nods
opioid
past
price
prices
Language
unset
Current search:
biogen
×
" bristol-myers squibb "
×
abbvie
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More